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Abstract 
NG2 is a type I transmembrane glycoprotein known as chondroitin sulfate proteoglycan 4 (CSPG4). In the healthy cen-
tral nervous system, NG2 is exclusively expressed by oligodendrocyte progenitor cells and by vasculature pericytes. A 
large body of immunohistochemical studies showed that under pathological conditions such as acute brain injuries 
and experimental autoimmune encephalomyelitis (EAE), a number of activated microglia were NG2 immuno-positive, 
suggesting NG2 expression in these cells. Alternative explanations for the microglial NG2 labeling consider the 
biochemical properties of NG2 or the phagocytic activity of activated microglia. Reportedly, the transmembrane NG2 
proteoglycan can be cleaved by a variety of proteases to deposit the NG2 ectodomain into the extracellular matrix. 
The ectodomain, however, could also stick to the microglial surface. Since microglia are phagocytic cells engulfing 
debris of dying cells, it is difficult to identify a genuine expression of NG2. Recent studies showing (1) pericytes giv-
ing rise to microglial after stroke, and (2) immune cells of NG2-EYFP knock-in mice lacking NG2 expression in an EAE 
model generated doubts for the de novo expression of NG2 in microglia after acute brain injuries. In the current study, 
we took advantage of three knock-in mouse lines (NG2-CreERT2,  CX3CR1-EGFP and NG2-EYFP) to study NG2 expres-
sion indicated by transgenic fluorescent proteins in microglia after tMCAO (transient middle cerebral artery occlu-
sion) or cortical stab wound injury (SWI). We provide strong evidence that NG2-expressing cells, including OPCs and 
pericytes, did not differentiate into microglia after acute brain injuries, whereas activated microglia did express NG2 in 
a disease-dependent manner. A subset of microglia continuously activated the NG2 gene at least within the first week 
after tMCAO, whereas within 3 days after SWI a limited number of microglia at the lesion site transiently expressed 
NG2. Immunohistochemical studies demonstrated that these microglia with NG2 gene activity also synthesized the 
NG2 protein, suggesting activated microglia as an additional source of the NG2 proteoglycan after acute brain injuries.
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Introduction
Nerve/glia antigen 2 (NG2), encoded by the cspg4 gene 
(for simplicity we will use NG2 gene instead of cspg4 
gene), is a single membrane-spanning proteoglycan with 
a large extracellular domain, and a short cytoplasmic tail 
[43, 57]. In the central nervous system (CNS) of rodents, 
the earliest NG2 expression was detected in vascular per-
icytes after embryonic day 10.5 (E10.5) [26, 47]. At E12.5, 
the NG2 gene starts to get activated in a small population 
of oligodendrocyte precursor cells (OPCs) in the ven-
tral brain, and subsequently the NG2 protein becomes 
immuno-detectable in OPCs with increasing proportion 
from E13.5 to birth [11, 44]. In the postnatal CNS, all 
OPCs express NG2, therefore they are also termed NG2 
glia [23, 42, 49]. Numerous studies using antibody immu-
nostaining and transgenic mouse models revealed that in 
the healthy CNS, the expression of NG2 is restricted to 
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OPCs and pericytes but cannot be detected in microglia 
or astrocytes [10, 11, 22–24, 28, 44].
The large extracellular domain of NG2 contains proteo-
lytic sites near the transmembrane domain, allowing the 
shedding of the NG2 ectodomain by various proteases 
such as MMP9, MMP13, MMP14, and the α-secretase 
ADAM10 [51, 57]. Under pathological conditions, 
glial cells are activated and NG2 expression is greatly 
enhanced in the injured area, contributing to the forma-
tion of the glial scar. Meanwhile, protease level in lesions 
also increases which could lead to significant deposition 
of the NG2 ectodomain in the extracellular matrix, there-
fore blurring the identification of NG2-expressing cells 
by immunohistochemistry [1, 51, 57].
Previous studies observed NG2 immunoreactivity in a 
subset of activated  Iba1+ microglia and/or macrophages 
(below referred to as microglia for simplicity) in a variety 
of disease models such as demyelination models induced 
by lysolecithin or experimental autoimmune encephalo-
myelitis (EAE) [3, 33, 40, 45], epilepsy model by kainate 
injection [6], neuroinflammation model by LPS injection 
[59, 62], or the acute injury models transient middle cer-
ebral artery occlusion (tMCAO) and stab wound injury 
(SWI) [18, 38, 52, 60]. However, whether microglia could 
express NG2 upon injury is still under debate, because 
previous studies were solely based on NG2 immunore-
activity possibly visualizing the shed ectodomain of NG2 
after phagocytosis in the inside or after unspecific depo-
sition on the surface of activated microglia [45, 51, 57]. 
In addition, although NG2 expression largely increased 
in the acutely injured area, the reported numbers of 
NG2 immuno-positive microglia varied from study to 
study. For example, Tanaka’s group showed that in rat 
brain lesions ~ 65% and ~ 80% of activated microglia dis-
played NG2 immunoreactivity to a commercial antibody 
at 7  days post tMCAO and SWI [38, 60], respectively. 
However, with a house-made antibody Hampton et  al., 
detected only ~ 20% of microglia with NG2 immunore-
activity along the lesion site at 2 days post SWI, and no 
NG2 immuno-positive microglia at 7  days post injury 
[18]. These seemingly contradictory results raise doubts 
that NG2 immuno-positive microglia are NG2-express-
ing cells in acute brain injury. The situation was further 
complicated by recent studies suggesting that pericytes 
(with bona fide expression of NG2) could generate micro-
glia after stroke [46]. In this case, NG2 could be detected 
as a remnant of a previous cell differentiation event.
On the other hand, the functions of NG2 in diseases 
were also investigated, though contradictory results 
appeared among different models. For example, Moran-
sard et  al., showed that NG2 detected in macrophages 
and OPCs was dispensable in an EAE model by using 
conventional NG2 knockout mice [40]. However, a recent 
study using NG2-EYFP knock-in (KI) mice in which 
the expression of EYFP was directly controlled by the 
endogenous NG2 gene activity demonstrated that NG2 
regulated neuroinflammation but was not expressed by 
immune cells in EAE, suggesting that the contribution of 
NG2 was derived mainly from OPCs and pericytes [28, 
30]. Therefore, it is important to examine whether micro-
glia are activated as sources and/or targets of NG2 in 
lesions.
In the current study, we used knock-in transgenic mice 
to investigate the controversial observations in tMCAO 
and SWI models. We crossbred the myeloid cell-spe-
cific GFP-expressing mice  (CX3CR1-EGFP KI) to NG2-
CreERT2 KI mice combined with a Rosa26-tdTomato 
(Ai14) reporter mouse line, thereby the activation of 
the NG2 gene in  EGFP+ cells would be traced in terms 
of tdTomato (tdT) expression upon tamoxifen induced 
Cre activity [24, 27, 36]. We also used NG2-EYFP KI 
mice to further confirm the direct gene activity of NG2 
after injury [28]. By combining immunohistochemical 
analysis and transgenic mouse techniques we were able 
to show that shortly after acute brain injuries a sub-
set of microglia indeed activated the NG2 locus leading 
to either EYFP expression or tdT recombination. These 
results suggest that a subset of microglia indeed activates 
the NG2 gene, leading to an NG2 transcript as well as a 
successful translation (NG2 protein). However, the time 
window of NG2 gene activation in microglia was longer 
lasting after tMCAO (at least the first week after occlu-
sion) than SWI (1–3 days).
Materials and methods
Ethics statements
This study was carried out at the University of Saarland 
in strict accordance with recommendations of European 
and German guidelines for the welfare of experimental 
animals. Animal experiments were approved by Saarland 
state’s “Landesamt für Gesundheit und Verbraucher-
schutz” in Saarbrücken/Germany (animal license num-
bers: 71/2010, 65/2013, 36/2016).
Animals
Mouse breeding and animal experiments were performed 
in the animal facilities of the University of Saarland. In 
this study only heterozygous adult mice (2–4 months old) 
were used to prevent knockin out alleles. Inducible Cre 
DNA recombinase knock-in mice NG2-CreERT2 were 
always used in combination with floxed reporter mice 
(TgH(ROSA26-CAG-fl-stop-sl-tdTomato) = Rosa26-
tdT) to show successful recombination (termed NG2-
CreERT2xRosa26-tdT mice) [24, 37]. To visualize 
microglia, the knock-in mouse line  CX3CR1-EGFP 
was used (TgH(CX3CR1-EGFP) = CXCREGFP) [27]. 
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NG2-CreERT2xRosa26-tdT mice were crossed to 
 CX3CR1-EGFP mice to generate triple transgenic mice 
termed  NG2tdTxCXCREGFP, simultaneously visualiz-
ing NG2-expressing cells and microglia upon tamoxifen 
administration. For visualization of NG2-expressing cells, 
the knock-in mouse line NG2-EYFP was analyzed [28].
Transient middle cerebral artery occlusion
The mice were anesthetized with a mixture of 2% isoflu-
rane and 47.5%  O2 and 47.5%  N2O using Harvard Appa-
ratus equipment. Focal cerebral ischemia was induced 
according to the Koizumi method of middle cerebral 
artery occlusion (MCAO) [31]. In short, the left com-
mon carotid artery (CCA) and the external carotid artery 
(ECA) were permanently ligated with silk sutures. A sili-
cone-coated filament (Doccol Corp, CA) was introduced 
through an arteriotomy and advanced into the right inter-
nal carotid artery (ICA) until mild resistance was felt, 
indicating the filament reached the origin of the MCA to 
occlude the blood flow. After 15 min occlusion the fila-
ment was withdrawn and a suture was made around the 
CCA, to prevent back flow through the arteriotomy.
Mouse body temperature was monitored throughout 
surgery, occlusion and reperfusion using a rectal ther-
mometer and maintained between 36.5 and 37.5  °C by 
an adjustable heat plate. After recovery from anesthesia, 
the mice were kept in their cages with free access to food 
and water. For three consecutive days the mice received 
0.5 mL subcutaneous injection of saline as fluid replace-
ment and intraperitoneal buprenorphine (0.01  µg/30  g 
body weight, Temgesic, Essex Pharma, Muenchen, Ger-
many) for pain relief. Mice were evaluated for neurologi-
cal deficits 2  h after the surgery as describe previously 
[38]. Only mice that developed obvious neurological defi-
cits (e.g. consistently circling to the paretic side or show-
ing reduced resistance to lateral push) were used for the 
following experiments. In total 27 mice were used for the 
tMCAO operation, in which five mice died (18.5%) before 
the end point of the experiment and two mice (7.4%) did 
not develop obvious neurological deficits.
Cortical stab wound injury model
Stab wound injury (SWI) was performed in anesthetized 
mice (ketamine  (Ketavet®, Pfizer, Germany)/xylazine 
 (Rumpon®, Bayer Healthcare, Germany) in 0.9% NaCl 
(140  mg/10  mg per 1  kg body weight)). The skull was 
thinned with dental drill laterally 1.5 mm and longitudi-
nally 2 mm from Bregma, followed by a 1 mm deep stab 
wound made with a scalpel [19].
After SWI the wound was closed and Buprenorphine 
(0.01  µg/30  g body weight, Temgesic, Essex Pharma, 
Muenchen, Germany) was injected for anti-pain treat-
ment. In total 17 mice were used for the SWI model and 
all mice survived after the surgery till the end point of the 
experiment.
TTC staining and measurement of the ischemic area
Mice were euthanized and decapitated 24  h after the 
MCAO operation. Brains were  dissected and cut into 
2 mm coronal sections. Brain sections were incubated in 
2% TTC (2,3,5-triphenyltetrazolium chloride) (Sigma, St. 
Louis, MO, USA) dissolved in PBS for 10 min at 37  °C. 
After washing by 1 × PBS, the brain sections were fixed 
in 4% PFA for 2  h. The images of stained sections were 
captured under a stereo-microscope (Stemi 2000-C, 
Zeiss, Göttingen, Germany) equipped with a digital cam-
era (AxioCam ERc 5s, Zeiss, Göttingen, Germany). The 
ischemic area was determined by measuring the regions 
that were not stained by TTC using ZEN software (Blue 
Edition, Zeiss, Oberkochen, Germany).
Immunohistochemistry
Mouse perfusion, tissue fixation and vibratome slice 
preparation (40  µm) was performed as described pre-
viously [2, 24]. The following primary antibodies were 
used: polyclonal goat: anti-GFP (1:1000, Rockland, Cat.: 
600101215) and anti-Iba1 (1:1000, Abcam, Cat.: ab5076); 
polyclonal chicken anti-GFP (1:1000, Invitrogen, Cat.: 
A10262); polyclonal rabbit: anti-NG2 (the extracellu-
lar domain) (1:500, Millipore, Cat.: ab5320), anti-Iba1 
(1:1000, Wako, Cat.: 01919741), monoclonal rat anti-
NG2 (AN2, the extracellular domain) (1:50, gift from Dr. 
Jacqueline Trotter) [41]. Secondary antibodies from don-
key (Alexa488-conjugated anti-chicken, Alexa555/647-
conjugated anti-rabbit, Alexa488/647-conjugated 
anti-goat (all 1:2000)) were from invitrogen, Grand Island 
NY, USA. Donkey Cy5-conjugated anti-rat IgG (1:500) 
antibody was purchased from Dianova, Hamburg, Ger-
many. 4′,6‐Diamidino‐2‐phenylindole (DAPI) (0.025  µg/
ml final concentration, from AppliChem, Darmstadt, 
Germany) was added to the secondary antibody dilutions 
for nuclear staining.
Tamoxifen‑induced gene recombination
Tamoxifen solution was prepared as previously described 
[23]. To induce reporter expression in  NG2tdTxCXCREGFP 
mice, tamoxifen was intraperitoneally injected (10 µg/ml, 
100 µl/10 g body weight) to mice once per day for three 
consecutive days according to described experiments in 
each figure.
Microscopic analysis and quantification
Epifluorescent images were collected by a fully auto-
mated slide scanner (AxioScan.Z1, Zeiss, Jena, Germany) 
equipped with an LED Light Source (Colibri 7, Zeiss, 
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Jena, Germany). The appropriate excitation and emission 
filters (excitation/emission wavelengths in nm) were set 
as: 353/465 (DAPI), 488/509 (green), 548/561 (red), and 
650/673 (infrared). A Plan-Apochromat 10 ×/0.45 objec-
tive for pre-focusing and a Plan-Apochromat 20 ×/0.8 
objective for fine focus image acquisition was used. 
Offline image stitching (8  μm stacks, variance projec-
tion) for overviews of brain slices and further analysis 
was performed using ZEN software (Blue Edition, Zeiss, 
Oberkochen, Germany).
Confocal images were taken using a laser-scanning 
microscope (LSM-710, Zeiss) as previously described 
[23]. Figures presented in this work were modified 
with Zen  1 software (Black Edition, Zeiss, Oberkochen, 
Germany).
Statistical analysis
For the tMCAO model, 2–6 sections per mouse and 
three to five mice per group were used. For SWI model, 
6–15 sections per mouse and at least five mice per group 
were analyzed. Data are presented as mean ± SEM of bio-
logical replicates (mice). The normal distribution of the 
data were confirmed by the Shapiro–Wilk test. To com-
pare the number of  tdT+  EGFP+ cells per slice (Figs. 1f, 
4f ), and the density of  tdT+  EGFP+ cells in Fig. 1g, one-
way ANOVA with Tukey’s post hoc multiple compari-
sons was performed. The levels of significance were set as 
*P < 0.05; ** < 0.01.
Results
NG2 was expressed in a subset of microglia after tMCAO
Previous studies demonstrated the NG2 immunoreac-
tivity in a significant number of microglia within the 
lesion area after tMCAO. However, those results from 
immunostaining against NG2 might be attributed to the 
expression of NG2 in microglia per se, or the shed ecto-
domain of NG2 after injury. To circumvent the short-
comings of immunohistochemistry for NG2, we took 
advantages of NG2-CreERT2xRosa26-tdT mice in which 
NG2-expressing cells could be traced by tdT expression 
upon tamoxifen administration, and  CX3CR1-EGFP 
mice in which myeloid cells including microglia 
and macrophages were visualized by EGFP expres-
sion. We crossed NG2-CreERT2xRosa26-tdT mice to 
 CX3CR1-EGFP mice to generate a new triple transgenic 
mouse line termed  NG2tdTxCXCREGFP, allowing visu-
alization of NG2-expressing cells and microglia simul-
taneously upon induction of Cre activity by tamoxifen 
(Fig. 1a).
To determine when, if any,  EGFP+ cells could 
turn on NG2 gene after tMCAO, we injected adult 
 NG2tdTxCXCREGFP mice with tamoxifen at 0–2, 2–4, or 
4–6 days post injury (dpi) for three consecutive days and 
analyzed at 7  days after the first tamoxifen injection (7, 
9, and 11 dpi, respectively) (Fig. 1b). To increase the via-
bility, animals got 15 min tMCAO before reperfusion to 
induce detectable infarction as previously described [48]. 
Determined by TTC staining, 25% of the area of coronal 
brain sections was affected by ischemia 24  h after the 
operation (Additional file  1: Fig. S1a–c). After tMCAO, 
we observed highly activated  EGFP+ cells in terms of 
increased fluorescent protein expression and cell den-
sity in many regions of the infarcted hemisphere of the 
brain, such as striatum, thalamus, hippocampus and 
cortex (Fig.  1c, bright green area, Additional file  1: Fig. 
S1d, e). In parallel, Cre activity induction generated tdT-
expressing cells all over the brain, including those infarct-
affected regions (Fig. 1c). Although in the gliosis area the 
majority of  tdT+ and  EGFP+ cells still did not overlap, we 
did detect a small number of  EGFP+ cells co-expressing 
tdT whenever Cre activity was induced after tMCAO. 
Microglia are known to display numerous morphologi-
cal changes upon stimulation [29]. We noticed that those 
 tdT+  EGFP+ cells also possessed diverse morphologies 
such as ramified, amoeboid, or round shapes, represent-
ing activated microglia and/or macrophages (Figs. 1d, e, 
3d, e) [14, 34]. In contrast, virtually no  tdT+  EGFP+ cells 
were found in the injured regions when tMCAO was per-
formed 10  days after tamoxifen administration (Fig.  2), 
suggesting  tdT+  EGFP+ cells resulted from acute NG2 
Fig. 1 Continuous NG2 gene activation in a subset of microglia after tMCAO. a Overview of transgene structures of mouse lines used in tMCAO 
model.  CX3CR1-EGFP, NG2-CreERT2, and Rosa26-tdTomato mice were crossbred to generate a triple transgenic mouse termed  NG2
tdTxCXCREGFP. 
b  NG2tdTxCXCREGFP mice were used for tMCAO. Subsequently injured mice were injected with tamoxifen (TAM) for three consecutive days from 
0 to 2 days post injury (0–2 dpi), 2–4 dpi, or 4–6 dpi, and were analyzed at 7, 9, and 11 dpi respectively (7 days after the first day of TAM injection). 
c Overview of a coronal brain section of a  NG2tdTxCXCREGFP mouse treated with TAM at 2–4 dpi after tMCAO.  EGFP+ microglia were drastically 
activated in the infarct-related area of the brain. d and e Magnified views from white boxes in c showing that in general the expression of EGFP 
(triangles) and tdT (open arrowheads) were found in distinct cell populations. However,  tdT+  EGFP+ cells (arrowheads) could also be observed. 
White boxes in d and e highlighted the morphology of  tdT+  EGFP+ cells representing activated microglia. f and g Quantification of  tdT+  EGFP+ 
cells in the infarcted striatum (depicted by the dashed line in c) when tamoxifen was injected at different time points, represented as either the 
numbers of  tdT+  EGFP+ cells per coronal brain slice (f) or the density of  tdT+  EGFP+ cells (g). The color coding shows the data points per animal 
(n = 3–5 mice indicated as big circles with 2–6 data points (small ones) per mouse). Scale bars = 1000 μm in c, and 50 μm in d and e 
(See figure on next page.)
Page 5 of 15Huang et al. acta neuropathol commun           (2020) 8:146  
Page 6 of 15Huang et al. acta neuropathol commun           (2020) 8:146 
gene activity in triggered microglia rather than from the 
differentiation of recombined NG2-expressing cells. We 
therefore conclude that a small population of microglia 
activated the NG2 gene after tMCAO.
To investigate the dynamic activation of the NG2 gene 
in microglia after tMCAO, we quantified the numbers 
of  tdT+  EGFP+ cells found in the ipsilateral striatum, 
the most affected region, from different time points of 
tamoxifen treatment. When Cre activity was induced at 
0–2 dpi, 15 ± 7  tdT+  EGFP+ cells could be found in the 
striatum per brain slice. The number of  tdT+  EGFP+ cells 
increased to 50 ± 21 per slice and then fell back to 23 ± 6 
per slice when tamoxifen was injected at 2–4 and 4–6 dpi, 
respectively (Fig. 1f ). The corresponding density of those 
detected  tdT+  EGFP+ cells also showed a similar trend 
along the time line of tamoxifen administration (24 ± 4, 
43 ± 17, and 22 ± 3 cells/mm2 from striatum treated with 
tamoxifen at 0–2, 2–4 and 4–6 dpi, respectively) (Fig. 1g, 
Fig. 2 No differentiation of NG2-expressing cells into microglia after tMCAO. a Scheme of transgene structures of the triple transgenic mouse line 
 NG2tdTxCXCREGFP used in tMCAO model. b Experimental plan:  NG2tdTxCXCREGFP mice were occluded (tMCAO) 10 days after the 3-day injection of 
tamoxifen (TAM) and were analyzed at 7 days post injury (dpi). c- d Representative confocal images from injured striatum showed that virtually 
all  tdT+ cells (including cells in oligodendrocyte lineage and pericytes labeled by PDGFRβ) were not co-expressing EGFP, and intermingled cells 
could be distinguished by the Z-stack images (d, orthogonal view of the corresponding white box in c). Very rarely  tdT+ EGFP+ cells (2 cells found 
in 18 brain slices from three mice, 6 slices per mouse) were detected as indicated in e (orthogonal view of the corresponding white box in c). Scale 
bar = 20 μm
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Additional file  1: Fig. S1f, g). In the contralateral hemi-
sphere, no  tdT+ cells with EGFP expression were found, 
indicating microglial NG2 activity was  triggered by the 
injury (Fig. 3a–c). Therefore, activation of the NG2 gene 
occurred constantly in a small population of micro-
glia after tMCAO. Furthermore, immunohistochemi-
cal experiments with antibodies against the extracellular 
domain of NG2 demonstrated that many of those  tdT+ 
Fig. 3 NG2 protein expression in some microglia after tMCAO. a Overview of transgene structures of the triple transgenic mouse line 
 NG2tdTxCXCREGFP used in tMCAO model. b Experimental plan:  NG2tdTxCXCREGFP mice were injected with tamoxifen (TAM) for three consecutive 
days from 2 to 4 days post injury (dpi) and were analyzed at 9 dpi in the tMCAO model. c Micrographs showing  EGFP+ cells and  tdT+ cells never 
overlapped in the contralateral hemisphere.  TdT+ cells displayed either morphology of oligodendrocyte lineage cells (open arrowheads) or vascular 
pericytes (open triangle). d and e Confocal images in the infarct region with  tdT+ EGFP+ cells immuno-positive (d) or immuno-negative (e) for NG2. 
Scale bars = 50 μm in c, 20 μm in d and e 
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 EGFP+ cells were immuno-positive for NG2 (Fig. 3d, e), 
suggesting that those  tdT+ microglia not only activated 
NG2 promoter but also synthesized NG2 protein.
Taken together, our current results from 
 NG2tdTxCXCREGFP mice provide strong evidence for 
an acute NG2 expression in a subset of microglia in the 
infarct-affected regions, at least within the first week 
after tMCAO.
SWI leads to the transient activation of the NG2 gene 
in a subset of microglia
Unlike tMCAO, SWI is type of acute brain injury with 
direct bleeding into the parenchyma. To investigate 
whether microglia also acquire a similar dynamic acti-
vation of the NG2 gene after cortical SWI, we used the 
 NG2tdTxCXCREGFP mice with the same tamoxifen induc-
tion protocols as used in the tMCAO model (Fig. 4a, b). 
Fig. 4 Transient activation of the NG2 gene upon SWI in a subset of microglia. a Schematic of transgene structures of  NG2tdTxCXCREGFP mice used 
in SWI model. b Experimental plan: Subsequently after SWI, injured  NG2tdTxCXCREGFP mice were injected with tamoxifen (TAM) for three consecutive 
days from 0 to 2 days post injury (0–2 dpi), 2–4 dpi, or 4–6 dpi, and were analyzed at 7, 9, and 11 dpi respectively. c Overview of a coronal brain 
section of a  NG2tdTxCXCREGFP mouse at 7 dpi treated with TAM at 0–2 dpi. Along the injury site in the cerebral cortex, activation of  EGFP+ microglia 
were detected in terms of increased cell density and EGFP expression. d Injured area (white box in c) shown in higher magnification. e Magnified 
view from white box in d showing a few  tdT+  EGFP+ cells (arrowheads) at the lesion site. f Numbers of  tdT+  EGFP+ cells found per coronal brain 
slice when tamoxifen was injected at different time points after SWI. The color coding shows the data points per animal (n = 3–5 mice indicated as 
big circles with 5–15 data points (small ones) per mouse). Scale bars = 1000 μm in c, 100 μm in d, and 50 μm in e 
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SWI triggered a substantial activation of microglia along 
the lesion site (Fig.  4c, d, bright green area). Tamoxifen 
treatment could always induce recombination of the 
tdT reporter over the whole brain including the injured 
area. Like in the tMCAO model, no tdT expression was 
detected in  EGFP+ cells outside the injured area. How-
ever, we could always observe a small number of  tdT+ 
 EGFP+ cells (~ 5 cells per brain slice) at the lesion site 
(within 300 µm of the stab wound) when tamoxifen was 
administered at 0–2 dpi (Figs.  4e, f, 5). The number of 
 tdT+  EGFP+ cells quickly decreased to less than ~ 1 cell/
per brain slice when tamoxifen was given later at 2–4 or 
4–6 dpi (Fig. 4f ). In addition, without tamoxifen we only 
observed very sporadic  tdT+ cells even at the lesion site 
that never co-expressed EGFP, indicating  tdT+  EGFP+ 
cells were not resulted from injury-induced spontane-
ous recombination (Additional file 1: Fig. S2). When Cre 
activity was induced 70 days before SWI, we detected a 
number of  tdT+ cells without any EGFP expression at 
the lesion site at 3 or 14 dpi, suggesting that  NG2+ cells 
did not differentiate into microglia (Additional file 1: Fig. 
S2). Notably, whenever tamoxifen was administered, we 
could detect cell debris of  tdT+ cells being phagocytosed 
by  EGFP+ microglia after SWI (Additional file 1: Fig. S3, 
 tdT+ particles wrapped by  EGFP+ cells), which could be 
easily distinguished from the  EGFP+ cells co-expressing 
tdT by their morphology. Therefore, the present results 
suggest that a small number of microglia at the lesion site 
transiently activated their NG2 gene shortly after SWI. 
To determine whether those NG2 gene-active microglia 
also produce the NG2 protein after SWI, we induced Cre 
activity at 0–2 dpi and performed immunohistochemis-
try for NG2 at 3, 7 or 28 dpi (Fig. 5a, b). In line with the 
results from the study for dynamic activation of NG2 gene, 
we only detected NG2 immunoreactivity on  tdT+  EGFP+ 
cells at 3 dpi, but never at 7 or 28 dpi (Fig. 5c–g). To fur-
ther confirm the NG2 expression in activated microglia 
after SWI, we took advantage of NG2-EYFP knock-in 
mice, which demonstrate endogenous NG2 gene activa-
tion as EYFP expression. We performed immunostaining 
against Iba1 (a marker for microglia) and NG2 at 3, 4, or 
5  day after SWI to seek microglia with EYFP and NG2 
expression (Fig.  6a, b). At 3  dpi, we detected few  NG2+ 
 Iba1+ cells expressing EYFP at the lesion site (Fig.  6c, d, 
arrowheads). These  EYFP+  Iba1+ cells showed amoeboid 
or round shape, representing activated microglia or mac-
rophage-like morphology. In addition, we also observed 
 NG2+  Iba1+ cells without EYFP expression (Fig. 6d, open 
arrowheads), possibly due to the degradation of EYFP 
after the transient activation of the NG2 gene. At 4 dpi, it 
became rather difficult to find  Iba1+ cells co-expressing 
EYFP (Fig. 6e). One day later (5 dpi) no overlay between 
EYFP-expressing cells and Iba1 immunoreactivity could be 
observed anymore (Fig. 6f). Regarding the half-life of jelly 
fish proteins (EGFP: ~ 26  h) [9], current studies of NG2-
EYFP mice suggested a time window of 1–3 days for the 
NG2 promoter activation in microglia after SWI, in line 
with results from  NG2tdTxCXCREGFP mice.
Discussion
Several previous studies detected NG2 immunoreactivity 
on microglia or macrophages in a variety of disease mod-
els. However, the existence of NG2-expressing microglia 
was still debated. Main reasons were alternative explana-
tions inherent to the biochemistry of NG2 itself and its 
cell biology. Both of which are difficult to be addressed 
by immunohistochemistry only: (1) the shed ectodomain 
of NG2 and a possible deposition at the lesion site, (2) 
differentiation of pericytes into microglia with residual 
NG2 protein, and (3) microglial phagocytotic activity of 
dying  NG2+ cells [45, 46, 51, 57]. Indeed, microglia could 
engulf myelin debris upon injury [5, 13, 50, 58]. Further-
more, a recent study using NG2-EYFP mice found no 
NG2-expressing immune cells in an EAE model, raising 
doubts for NG2-expression by microglia in other disease 
models [30]. In the present study, we took advantage of 
the direct fluorescent protein expression in the triple 
transgenic mouse line  NG2tdTxCXCREGFP to circumvent 
the shortcomings of immunohistochemical studies of 
NG2 expression in microglia, by temporally controlling 
the induction of Cre DNA recombinase activity.
When Cre activity was induced before tMCAO or SWI, 
we virtually never detected  tdT+  EGFP+ cells, indicating 
that NG2-expressing cells, including NG2 glia and peri-
cytes, do not differentiate into microglia. Our results were 
Fig. 5 NG2 gene-activated microglia with NG2 protein expression within short time after SWI. a Overview of transgene structures of 
 NG2tdTxCXCREGFP mice used in SWI model. b Experimental design: After SWI,  NG2tdTxCXCREGFP mice were injected with TAM from 0 to 2 dpi, and 
analyzed at 3, 7, or 28 dpi. c–f Confocal images showing NG2 immunoreactivity in  tdT+,  EGFP+ cells at the lesion site at 3 dpi (c, d), and 7 dpi (e, f). 
EGFP (triangles) and tdT (open arrowheads) were mostly expressed in different cell types, with exceptions of a few  tdT+ EGFP+ cells detected at the 
lesion site (arrowheads). The immunoreactivity to NG2 was detected in some  tdT+  EGFP+ cells (arrows indicate the NG2 positive processes) at 3 dpi 
(d, magnifying the white box in c) but undetectable at 7 dpi (f, magnifying the white box in e), whereas most cells expressing only tdT (arrowheads) 
were always NG2 immunopositive with some exceptions indicating their differentiation into mature oligodendrocytes. g Confocal images showing 
a  tdT+  EGFP+ cell found at 28 dpi, with the orthogonal view (right image). Scale bars = 20 μm in c, e, f, and 10 μm in d, g 
(See figure on next page.)
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in line with previous studies demonstrating that NG2 glia/
OPCs did not generate microglia, as well as a recent study 
using Tbx18-CreERT2 mice showing that pericytes did not 
behave as stem cells to differentiate into other cells types in 
a variety of disease models including SWI [16, 42]. Nota-
bly, some studies suggested that pericytes might give rise 
Fig. 6 Few microglia in NG2-EYFP mice with NG2 promotor activity after SWI. a Schematic of transgene structure of NG2-EYFP mice used in 
SWI model. b Experimental plan: NG2-EYFP mice were analyzed at 3, 4, or 5 dpi (SWI). c and d Confocal micrographs showing  EYFP+,  Iba1+, and 
 NG2+ cells at the lesion site at 3 dpi. A few  NG2+  Iba1+ cells could be detected at the lesion site with (arrowheads in c and d) or without (open 
arrowheads in d) expression of EYFP. e and f Confocal images showing EYFP and Iba1 immuno-positive cells at the injured area at 4 (e) and 5 (f) dpi. 
 EYFP+  Iba1+ cells could be rarely observed at 4 dpi (e, white box showing an example magnified in the right image), and were almost undetectable 
at 5 dpi (g, white box was shown as orthogonal view in the right image). Scale bars = 20 μm
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to microglia after injury. For example, RGS5 (regulator of 
G-protein signaling 5) is another marker of pericytes. In a 
permanent MCAO stroke model using RGS5-GFP mice 
 GFP+ cells were immuno-positive for microglial mark-
ers [46]. However, microglia were reported to transiently 
express non-microglial genes upon activation [53], there-
fore, it was possible that the RGS-5 promoter was somehow 
induced in microglia after stroke, enabling the GFP expres-
sion. On the other hand, we cannot rule out that differences 
of disease models triggered pericytes to behave differently. 
Nevertheless, our current results showing NG2-expressing 
cells did not generate microglia further confirmed that 
 tdT+  EGFP+ cells being detected when Cre activity was 
induced after injuries were indeed due to the activation of 
the NG2 gene in a subset of microglia.
Transient MCAO induced long-lasting brain dam-
age, while after cortical SWI the wound healed quickly 
with reduced glia activation [12, 20, 35, 39]. With 
 NG2tdTxCXCREGFP mice, we were able to show that the 
generation and the time frame of appearance of NG2-
expressing microglia also differed in those two injury mod-
els by inducing Cre activity at different time points. In 
tMCAO, a small population of  EGFP+ microglia continu-
ously activated the NG2 gene in terms of tdT expression at 
least in the first post-lesion week, whereas microglial NG2 
gene activity could only be detected at the lesion site shortly 
after SWI. In addition, we observed more  tdT+EGFP+ cells 
when  NG2tdTxCXCREGFP mice were treated with tamoxifen 
at 2–4  days post tMCAO, coincident with previous stud-
ies demonstrating the MCAO-induced damage developed 
progressively to reach the peak at 2–3 dpi [20, 35]. There-
fore, the present results suggest that microglial NG2 gene 
activation is dependent on the type and severity of injury.
Our immunohistochemical experiments detected a 
subset of  tdT+  EGFP+ cells with NG2 immunoreactivity 
in both injury models, strongly suggesting that those cells 
also express NG2 protein. After SWI, the detectable NG2 
immunoreactivity in microglia in  NG2tdTxCXCREGFP 
mice or in NG2-EYFP mice all showed up within the 
first 3  days, generally consistent with the NG2 gene 
activity revealed by reporter gene expression. How-
ever, in  NG2tdTxCXCREGFP mice we also found some 
 tdT+  EGFP+ cells without NG2 immunoreactivity in the 
tMCAO model which triggered continuous activation of 
NG2 gene as well as at 3 dpi in the SWI model. Because 
Cre mediated recombination generated permanent tdT 
expression, those observations of NG2 immuno-nega-
tive  tdT+  EGFP+ cells could be interpreted in such way, 
that the NG2 protein had been already degraded. On 
the other hand, it has been reported that some cortical 
neurons in the postnatal brain could acquire slight NG2 
gene activity leading to the reporter recombination in 
NG2-CreERT2xRosa26-tdT mice, but without inducing 
the expression of NG2 protein [24]. Therefore, we could 
also conceive that some microglia possessed moderate 
NG2 gene activity after injury which enabled only the 
expression of Cre rather than endogenous NG2 protein. 
Nevertheless, although the dynamic regulation of NG2 
protein in microglia remains to be elucidated, our current 
results provide strong evidence that microglia are one of 
the sources of NG2 protein after acute brain injuries.
Although we observed significant numbers of  tdT+  EGFP+ 
cells in our tMCAO model, the number of  tdT+  EGFP+ cells 
was still lower than numbers of  NG2+ microglia found in 
previous studies in rat (~ 60%) [38, 55]. The brain damage 
increased with the occlusion period in the tMCAO model, 
which might account for the discrepancy detected in those 
studies (15 and 90 min in the present and previous studies, 
respectively) [38, 55]. Of note, in SWI models the number of 
 tdT+  EGFP+ cells found in the present mouse study was also 
much lower than the number of microglia with NG2 immu-
noreactivity found in rat (at least 20%) [17, 60]. Therefore, we 
cannot rule out that the species difference regarding NG2 
gene activity contributed to the discrepancy among those 
studies as well. The biological significance of the NG2 pro-
teoglycan generated from microglia in our models remains 
to be determined. Further experiments combining NG2 
floxed mice [8] and microglia-Cre expressing mice (such as 
 CX3CR1-Cre [61]), however, will facilitate the study of func-
tions of the NG2 expressed by microglia.
The NG2 immunoreactivity in microglia is not 
restricted to tMCAO and SWI, as it was studied by us, it 
was also reported in other rodent models of CNS trauma 
such as spinal cord injury (SCI) or LPS-induced inflam-
mation [25, 62]. Moreover, several studies suggest that 
the NG2 proteoglycan is involved in axon growth and 
inflammatory response [21, 32, 56], and transplantation of 
 NG2+ microglia ameliorated ischemic damage in rat brain 
[52]. On the other hand, previous immunohistochemi-
cal studies in human specimen suggested a similar NG2 
expression pattern as in rodents. For example, NG2 could 
be detected in OPCs and pericytes in the healthy human 
CNS and was also found upregulated under pathologi-
cal conditions [4, 54]. Furthermore, NG2 was immuno-
detectable in microglia/macrophages in samples from 
patients who encountered acute CNS injuries such as SCI 
or stroke, though the functions were not determined [7, 
52]. Therefore, combined with other techniques such as 
genetic cell ablation [15],  NG2tdTxCXCREGFP mice would 
be a valuable tool for the mechanistic study of the genera-
tion and function of NG2-expressing microglia, as well as 
the contribution of NG2 derived from distinct cell popu-
lations in different diseases.
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